KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 71 filers reported holding KRONOS BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,165,536 | -24.4% | 1,665,797 | 0.0% | 0.05% | -14.8% |
| Q2 2023 | $2,865,171 | +272.0% | 1,665,797 | +215.8% | 0.06% | +84.8% |
| Q1 2023 | $770,150 | -9.9% | 527,500 | 0.0% | 0.03% | -19.5% |
| Q4 2022 | $854,550 | -51.6% | 527,500 | 0.0% | 0.04% | -61.0% |
| Q3 2022 | $1,767,000 | -8.0% | 527,500 | 0.0% | 0.10% | -18.6% |
| Q2 2022 | $1,920,000 | -49.7% | 527,500 | 0.0% | 0.13% | -31.4% |
| Q1 2022 | $3,814,000 | -46.8% | 527,500 | 0.0% | 0.19% | -43.4% |
| Q4 2021 | $7,169,000 | -35.2% | 527,500 | 0.0% | 0.33% | -34.4% |
| Q3 2021 | $11,056,000 | -12.5% | 527,500 | 0.0% | 0.51% | -10.0% |
| Q2 2021 | $12,634,000 | -18.2% | 527,500 | 0.0% | 0.56% | -17.0% |
| Q1 2021 | $15,440,000 | -2.0% | 527,500 | 0.0% | 0.68% | -24.9% |
| Q4 2020 | $15,756,000 | – | 527,500 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
| Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
| Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
| Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
| Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
| Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
| Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
| Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
| Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |